University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Jinoos Yazdany, M.D., M.P.H.

Associate clinical director of the Lupus Clinic

Dr. Jinoos Yazdany is a rheumatologist specializing in systemic lupus erythematosus (SLE). She currently serves as the associate director of the Lupus Clinic. Her research focuses on developing clinical quality measures in SLE, which aim to improve and standardize care for this condition.

Yazdany received a medical degree from UCLA and completed her M.P.H. at Harvard University. Yazdany has a co-chair appointment to the American College of Rheumatology (ACR) Quality Measures Subcommittee and she serves on the National Quality Forums Health Professional's Council. She was awarded a Physician Scientist Development Award from the ACR in 2005 and an Arthritis Investigator Award from the Arthritis Foundation in 2007 for her work examining quality of care in SLE.

Clinics

Lupus Clinic
400 Parnassus Ave., Floor B1
San Francisco, CA 94143
Phone: (415) 353-2497
Fax: (415) 353-2530

Hours: Monday to Friday,
8 a.m. to 4 p.m.

Conditions & Treatments

More about Jinoos Yazdany

Additional Languages

Farsi

Education

UCLA School of Medicine 2000

Residencies

UCSF Medical Center, Internal Medicine 2003

Selected Research and Publications

  1. Rai SK, Yazdany J, Fortin PR, Aviņa-Zubieta JA. Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Arthritis Res Ther. 2015; 17:143.
  2. Duseja R, Bardach NS, Lin GA, Yazdany J, Dean ML, Clay TH, Boscardin WJ, Dudley RA. Revisit Rates and Associated Costs After an Emergency Department Encounter: A Multistate Analysis. Ann Intern Med. 2015 Jun 2; 162(11):750-756.
  3. Yazdany J, Dudley RA, Chen R, Lin GA, Tseng CW. Coverage for high-cost specialty drugs for rheumatoid arthritis in medicare part d. Arthritis Rheumatol. 2015 Jun; 67(6):1474-80.
  4. Yelin E, Yazdany J, Tonner C, Trupin L, Criswell LA, Katz P, Schmajuk G. Interactions between patients, providers, and health systems and technical quality of care. Arthritis Care Res (Hoboken). 2015 Mar; 67(3):417-24.
  5. Schmajuk G, Bozic KJ, Yazdany J. Using medicare data to understand health care value-reply. JAMA Intern Med. 2015 Mar 1; 175(3):462-3.
  6. Lawson EF, Trupin L, Yelin EH, Yazdany J. Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2015 Jan 22.
  7. Andrews JS, Trupin L, Schmajuk G, Barton J, Margaretten M, Yazdany J, Yelin EH, Katz PP. Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 Jan; 67(1):120-7.
  8. Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J, Margaretten M, Katz PP, Yelin EH, Yazdany J. Infection is the leading cause of hospital mortality in patients with dermatomyositis/polymyositis: Data from a population-based study. Arthritis Care Res (Hoboken). 2014 Oct 20.
  9. Schmajuk G, Bozic KJ, Yazdany J. Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections. JAMA Intern Med. 2014 Oct; 174(10):1702-4.
  10. Yazdany J, Marafino BJ, Dean ML, Bardach NS, Duseja R, Ward MM, Dudley RA. Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation. Arthritis Rheumatol. 2014 Oct; 66(10):2828-36.
  11. Yazdany J, Tonner C, Schmajuk G, Lin GA, Trivedi AN. Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014 Oct; 66(10):1447-55.
  12. Quinzanos I, Davis L, Keniston A, Nash A, Yazdany J, Fransen R, Hirsh JM, Zell J. Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic. Lupus. 2015 Feb; 24(2):203-9.
  13. Schmajuk G, Miao Y, Yazdany J, Boscardin WJ, Daikh DI, Steinman MA. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Arthritis Care Res (Hoboken). 2014 Aug; 66(8):1159-66.
  14. Katz P, Trupin L, Rush S, Yazdany J. Longitudinal validation of the Brief Index of Lupus Damage. Arthritis Care Res (Hoboken). 2014 Jul; 66(7):1057-62.
  15. Simard JF, Yazdany J. Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE. Lupus Sci Med. 2014; 1(1):e000035.
  16. Askanase AD, Yazdany J, Molta CT. Post-marketing experiences with belimumab in the treatment of SLE patients. Rheum Dis Clin North Am. 2014 Aug; 40(3):507-17, viii.
  17. Drenkard C, Yazdany J, Trupin L, Katz PP, Dunlop-Thomas C, Bao G, Lim SS. Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken). 2014 Jun; 66(6):888-96.
  18. Lawson EF, Hersh AO, Trupin L, von Scheven E, Okumura MJ, Yazdany J, Yelin EH. Educational and vocational outcomes of adults with childhood- and adult-onset systemic lupus erythematosus: nine years of followup. Arthritis Care Res (Hoboken). 2014 May; 66(5):717-24.
  19. Yazdany J, Feldman CH, Liu J, Ward MM, Fischer MA, Costenbader KH. Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States. Arthritis Care Res (Hoboken). 2014 Apr; 66(4):617-24.
  20. Yazdany J, Trupin L, Schmajuk G, Katz PP, Yelin EH. Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study. BMJ Qual Saf. 2014 Aug; 23(8):659-66.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.